Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kemira is a global leader in sustainable chemical solutions for water-intensive industries, including pulp & paper, water treatment, and specialty chemicals. It formerly supplied acetate and formic acid products for the pharmaceutical industry but largely divested direct pharma manufacturing solutions in 2013. Kemira's recent focus in biotech is on enzyme-catalyzed polymer production for packaging and water sectors through exclusive partnerships with firms like IFF and DuPont. Kemira is not a biotech, pharma, or CRO company; it is an industrial chemical company. While it develops biotechnology-enabled polymer technologies, these target material sciences and packaging, not health or therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kemira.